| Reckitt Benckiser (Switzerland) AG - Gavisconell Liquid Mint, Suspension zum Einnehmen in Flaschen | | 66997 | | 01 | | Gavisconell Liquid Mint | | Suspension zum Einnehmen in Flaschen | | A02AX | | Antacids, Other Combinations | | 01.11.2018 | | |
| | Composition | | natrii alginas 500 mg, natrii hydrogenocarbonas 267 mg, calcii carbonas 160 mg, carbomerum 974P, natrii hydroxidum ad pH, aqua purificata, menthae piperitae aetheroleum, saccharinum natricum, propylis parahydroxybenzoas 6 mg, E 218 40 mg, ad suspensionem pro 10 ml corresp. natrium 142.6 mg. | | Packungsbestandteile | | Suspension zum Einnehmen in Flaschen | | | | | | | | Active Agent | Dose |
|---|
| Calcium Carbonate | 160 mg | | Sodium Alginate | 500 mg | | Sodium Hydrogen Carbonate | 267 mg |
| | BAG: Active Agent | Dose |
|---|
| Calcium Carbonate | 160 mg | | Sodium Alginate | 500 mg | | Sodium Hydrogen Carbonate | 267 mg |
| | | | Inactive agents | | additional_information |
|---|
| Aromatica | | | | E 218 | | conserv. | | Propylis Parahydroxybenzoas | | conserv. | | Saccharinum Natricum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 150 ml | | | D | | Yes | | 002 | 300 ml | 5.83 | 10.75 | D | SL | No |
|
|
